Clinical Trials Browser

Phase 1/2 × INDUSTRY × Neurofibromatoses × Clear all

NCT05011019 2024-03-21

A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurofibromatosis

Phase 1/2 Terminated

Neurofibromatoses, Neurofibrosarcoma